KCER: Kidney Community Emergency Response Coalition

Welcome to the KCER Website

Should you require assistance during an emergency, please reference the resources below:

A disaster is an event that can result in significant harm to lives and/or property, as well as disruption in daily activities. For the people receiving kidney dialysis or living with a kidney transplant, planning for emergencies and disasters can be the difference between life and death. Dialysis and kidney transplant patients must take special preparedness measures to ensure their own health and safety during and after disasters.

The Kidney Community Emergency Response (KCER) Coalition provides technical assistance to ESRD Networks, Medicare organizations, and other groups to ensure timely and efficient disaster preparedness, response, and recovery for the kidney community.

The KCER Coalition strives to provide disaster preparedness resources to save lives, improve outcomes, empower patients and families, educate healthcare workers, build partnerships with stakeholders, promote readiness in the community, and support the ESRD Network Program.

Take a few minutes to browse the information about the Coalition; Response Teams; and resources for patients, providers, ESRD Networks, and emergency management. Feel free to contact us with any questions.

The Hurricane Sandy After Action Report is also now available. Please click this link to download the report.

The Hurricane Isaac After Action Report is also available. Please click this link to download the report.

KCER Webinar - Emergency Preparedness and Response for the Dialysis and Transplant Community: What You Need to Know! - December 18, 2012

Please visit the links below to download the presentation and recording:

KCER 8th Summit Meeting: In the Eye of the Storm - December 12, 2012

Please visit the link below to download the presentation:

KCER Community Partners Meeting - December 6, 2012

Please visit the links below to download the presentation and recording:

Snowstorm NEMO 2013 Response

KCER is available to provide assistance to the renal community. The toll-free KCER Emergency Hotline for patients and providers is 866-901-3773.

Previous Hurricane Sandy updates can be found at Severe Weather Alerts and Response.

* To locate a flu vaccine provider nearest to you, enter your city, state or zip code in the search line above and click "Go".

Alerts and Recall Notifications

This section will display all of the latest updates from KCER. Please click here for additional alerts.

December 27, 2012

Heparin: Drug Safety Communication - Important change to heparin container labels to clearly state the total drug strength

Audience: Health Professionals, Patients, Home Care

Issue: FDA is notifying health care professionals, caregivers, and patients about a change to the container and carton labels for heparin products.

This label change will require manufacturers of Heparin Lock Flush Solution, USP and Heparin Sodium Injection, USP to clearly state the strength of the entire container of the medication followed by how much of the medication is in 1 milliliter (mL). These modifications will eliminate the need for health care professionals to calculate the total amount of heparin medication in a product containing more than 1 mL, thereby reducing the risk of miscalculations that may result in medication errors.

Click here for additional details, recommendations and contact information.

November 20, 2012

HeartSine Samaritan Public Access Defibrillator 300/300P: Class I Recall - Device May Intermittently Turn On and Off

Audience: Risk Managers, Health Professionals

Issue: HeartSine notified customers that certain Samaritan 300/300P PAD devices have been found to intermittently turn on and off, which may eventually deplete the battery. In addition and separately, certain Samaritan 300/300P PAD devices containing early versions of the battery management software may misinterpret a temporary drop in battery voltage as signaling a low battery, resulting in the device turning itself off. A device experiencing either condition could be unable to deliver therapy during a cardiac event. A list of serial numbers affected by this recall is provided.

Click here for additional details, recommendations and contact information.

November 9, 2012

Baxter Healthcare Corp. Buretrol Solution Sets:
Class 1 Recall - May Not Function as Expected

Audience: Risk Managers

Issue: Baxter Healthcare Corp. (Baxter) has initiated a voluntary recall of its Buretrol Solution Sets because the ball-valve feature may not function as expected. Baxter has determined that the ball-valve component is allowing air to flow past the valve and enter the tubing once the pre-measured amount of fluids is completely administered to the patient. If the air is not removed, the air present in the tubing may enter the patient's vascular system potentially causing air in the bloodstream (an air embolism). This product may cause serious adverse health consequences, including death.

Click here for additional details, recommendations and contact information.

November 2, 2012

FDA Safety Announcement: Ameridose, LLC: Recall of Unexpired Products in Circulation

Audience: Risk Manager, Healthcare Professionals

Issue: The U.S. Food and Drug Administration announced today that Ameridose, LLC, based in Westborough, Mass., is voluntarily recalling all of its unexpired products in circulation. The FDA is currently conducting an inspection of the Ameridose facility. Although this inspection is ongoing, the FDA's preliminary findings have raised concerns about a lack of sterility assurance for products produced at and distributed by this facility. Use of non-sterile injectable products can represent a serious hazard to health that could lead to life-threatening injuries. Products from Ameridose can be identified by markings that indicate Ameridose by name or by its company logo. A complete list of all products subject to this recall can be accessed at www.ameridose.com.

Click here for additional details, recommendations and contact information.

October 29, 2012

FDA Safety Announcement: Hospira Symbiq Infusion System Touchscreen: Class 1 Recall - May Not Respond to Selection
16026 Symbiq One Channel Infuser
16027 Symbiq Two Channel Infuser

Audience: Risk Manager, Nursing, Biomedical Engineering

The FDA notified healthcare professionals and provider organizations of the Class 1 recall of the Symbiq pump touchscreen. These devices may not respond to user selection, may experience a delayed response or may register a different value from the value selected by the user. Failure of the touchscreen to respond to user input could result in a delay or interruption in therapy or over delivery or under delivery of medication if the user does not confirm the programmed values on the pump's confirmation screen before starting the infusion. All serial numbers for these models are affected by this recall.

Click here for additional details, recommendations and contact information.

Disaster Preparedness: A Guide for Chronic Dialysis Facilities

The Kidney Community Emergency Response (KCER) Coalition is pleased to announce the release of the CMS publication, Disaster Preparedness: A Guide for Chronic Dialysis Facilities – Second Edition located on the KCER website. This updated and informative document is intended to replace the original CMS Emergency Preparedness for Dialysis Facilities Manual and can easily be downloaded, saved for reference, printed if desired, and used in facilities across the country.  In addition to being placed on the home page of the KCER website, the new guide along with a Word document containing customizable forms from the appendix, will permanently reside on both the Healthcare Providers and ESRD Network subpages of the site under the titles:

Please take the time now to download, review, and apply the information and resources contained in this guide!